Incyte INCB018424 Cream

An Open-Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
To evaluate the safety and tolerability of INCB018424 cream applied to pediatric subjects with eczema
CHLA IRB Number
CHLA-17-00541
Eligibility
Children ages 2 to 11 years of age with mild to moderate eczema (atopic dermatitis)
Enrollment Status
Closed
Does this study also recruit healthy volunteers?
No
Contact Email
pyong@chla.usc.edu